Contact us
Request access to the first AI system trained on 1M+ outcome-linked papers across 5,846 rare diseases – forecasting probability of success for early-stage therapies years before clinical signals emerge.
De-risk pipeline
Make confident early-stage R&D and investments choices with drug discovery landscapes for 5,846 rare diseases featuring probability of success forecasts.
Monitor opportunities
Continuous monitoring of emerging novel therapies with the highest approval potential, delivered as memorandums personalized to specific pipelines.
Repurpose drugs
Selecting and ranking successful opportunities for therapeutic repurposing by targets and mechanisms across more than 1 million drug discovery publications.
